These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32118559)

  • 1. Hospital Care of Opioid-Exposed Newborns: Clinical and Psychosocial Challenges.
    Goyal NK; McAllister J
    J Hosp Med; 2020 Oct; 15(10):613-618. PubMed ID: 32118559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
    Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
    Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Within-Hospital Concordance of Opioid Exposure Diagnosis Coding in Mothers and Newborns.
    Clark RRS; French R; Lorch S; O'Rourke K; Rosenbaum KEF; Lake ET
    Hosp Pediatr; 2021 Aug; 11(8):825-833. PubMed ID: 34230061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal Opioid Use Disorder and Neonatal Abstinence Syndrome Among Rural US Residents, 2007-2014.
    Kozhimannil KB; Chantarat T; Ecklund AM; Henning-Smith C; Jones C
    J Rural Health; 2019 Jan; 35(1):122-132. PubMed ID: 30370563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
    Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
    Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnant women with opioid use disorder and their infants in three state Medicaid programs in 2013-2016.
    Clemans-Cope L; Lynch V; Howell E; Hill I; Holla N; Morgan J; Johnson P; Cross-Barnet C; Thompson JA
    Drug Alcohol Depend; 2019 Feb; 195():156-163. PubMed ID: 30677745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015.
    Dave CV; Goodin A; Zhu Y; Winterstein A; Wang X; Alrwisan A; Hartzema A
    Pharmacotherapy; 2019 Oct; 39(10):1005-1011. PubMed ID: 31361913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes.
    Jones HE; Heil SH; Tuten M; Chisolm MS; Foster JM; O'Grady KE; Kaltenbach K
    Drug Alcohol Depend; 2013 Aug; 131(3):271-7. PubMed ID: 23279924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse neonatal outcomes associated with maternal severe mental health diagnoses and opioid use.
    Ma J; Sahasranaman V; Kirby RS; Boaz T
    J Perinatol; 2020 Oct; 40(10):1497-1505. PubMed ID: 32753708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in maternal opioid use disorder and neonatal abstinence syndrome in Maine, 2016-2022.
    Dudley J; Gabrielson SMB; O'Connor AB; Ahrens KA
    J Perinatol; 2024 Aug; 44(8):1104-1110. PubMed ID: 38267636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal Abstinence Syndrome In The United States, 2004-16.
    Leech AA; Cooper WO; McNeer E; Scott TA; Patrick SW
    Health Aff (Millwood); 2020 May; 39(5):764-767. PubMed ID: 32364857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses: Analysis of ICD-10-CM Transition, 2013-2017.
    Ko JY; Hirai AH; Owens PL; Stocks C; Patrick SW
    Hosp Pediatr; 2021 Aug; 11(8):902-908. PubMed ID: 34321311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. US Hospital Data About Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses.
    Meyer M; Metayer J
    JAMA; 2021 May; 325(20):2119-2120. PubMed ID: 34032837
    [No Abstract]   [Full Text] [Related]  

  • 14. An Outpatient Methadone Weaning Program by a Neonatal Intensive Care Unit for Neonatal Abstinence Syndrome.
    Lai A; Philpot P; Boucher J; Meyer A
    Popul Health Manag; 2017 Oct; 20(5):397-401. PubMed ID: 28430046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between gestational age and the severity of neonatal abstinence syndrome.
    Gibson KS; Stark S; Kumar D; Bailit JL
    Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in incidence of neonatal abstinence syndrome in Canada and associated healthcare resource utilization.
    Filteau J; Coo H; Dow K
    Drug Alcohol Depend; 2018 Apr; 185():313-321. PubMed ID: 29486420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ohio Perinatal Quality Collaborative Improves Care of Neonatal Narcotic Abstinence Syndrome.
    Walsh MC; Crowley M; Wexelblatt S; Ford S; Kuhnell P; Kaplan HC; McClead R; Macaluso M; Lannon C;
    Pediatrics; 2018 Apr; 141(4):. PubMed ID: 29514974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal Abstinence Syndrome: Review of Epidemiology, Care Models, and Current Understanding of Outcomes.
    MacMillan KDL
    Clin Perinatol; 2019 Dec; 46(4):817-832. PubMed ID: 31653310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. US Hospital Data About Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses-Reply.
    Hirai AH; Ko JY; Patrick SW
    JAMA; 2021 May; 325(20):2120. PubMed ID: 34032835
    [No Abstract]   [Full Text] [Related]  

  • 20. Can umbilical cord testing add to maternal urine drug screen for evaluation of infants at risk of neonatal opioid withdrawal syndrome?
    Gersch H; Shah D; Chroust A; Bailey B
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2211706. PubMed ID: 37183045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.